Evidence map›Paper›PMID 27708140›Full record

ArticleMolecular biology of the cell2016

The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-binding protein TIS11b/BRF1.

Felicitas Rataj, Séverine Planel, Agnès Desroches-Castan, Juliette Le Douce, Khadija Lamribet, Josiane Denis, Jean-Jacques Feige, Nadia Cherradi

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Prostaglandin EInflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Article
  7. AU-rich element-binding proteins in colorectal cancer.World journal of gastrointestinal oncology · 2019
    Review
  8. Review
  9. Article
  10. The role of RNA-binding protein tristetraprolin in cancer and immunity.Medical oncology (Northwood, London, England) · 2017
    Review
  11. ACTH Action on Messenger RNA Stability Mechanisms.Frontiers in endocrinology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Felicitas RatajInstitut National de la Santé et de la Recherche Médicale, INSERM U1036, Commissariat à l'Energie Atomique et aux Energies Alternatives, Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie du Cancer et de l'Infection, and Université Grenoble Alpes, Unité Mixte de Recherche-S1036, F-38000 Grenoble, France.
Séverine PlanelInstitut National de la Santé et de la Recherche Médicale, INSERM U1036, Commissariat à l'Energie Atomique et aux Energies Alternatives, Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie du Cancer et de l'Infection, and Université Grenoble Alpes, Unité Mixte de Recherche-S1036, F-38000 Grenoble, France.
Agnès Desroches-CastanInstitut National de la Santé et de la Recherche Médicale, INSERM U1036, Commissariat à l'Energie Atomique et aux Energies Alternatives, Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie du Cancer et de l'Infection, and Université Grenoble Alpes, Unité Mixte de Recherche-S1036, F-38000 Grenoble, France.
Juliette Le DouceInstitut National de la Santé et de la Recherche Médicale, INSERM U1036, Commissariat à l'Energie Atomique et aux Energies Alternatives, Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie du Cancer et de l'Infection, and Université Grenoble Alpes, Unité Mixte de Recherche-S1036, F-38000 Grenoble, France.
Khadija LamribetInstitut National de la Santé et de la Recherche Médicale, INSERM U1036, Commissariat à l'Energie Atomique et aux Energies Alternatives, Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie du Cancer et de l'Infection, and Université Grenoble Alpes, Unité Mixte de Recherche-S1036, F-38000 Grenoble, France.
Josiane DenisInstitut National de la Santé et de la Recherche Médicale, INSERM U1036, Commissariat à l'Energie Atomique et aux Energies Alternatives, Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie du Cancer et de l'Infection, and Université Grenoble Alpes, Unité Mixte de Recherche-S1036, F-38000 Grenoble, France.
Jean-Jacques FeigeInstitut National de la Santé et de la Recherche Médicale, INSERM U1036, Commissariat à l'Energie Atomique et aux Energies Alternatives, Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie du Cancer et de l'Infection, and Université Grenoble Alpes, Unité Mixte de Recherche-S1036, F-38000 Grenoble, France.
Nadia CherradiInstitut National de la Santé et de la Recherche Médicale, INSERM U1036, Commissariat à l'Energie Atomique et aux Energies Alternatives, Institut de Biosciences et Biotechnologies de Grenoble, Laboratoire Biologie du Cancer et de l'Infection, and Université Grenoble Alpes, Unité Mixte de Recherche-S1036, F-38000 Grenoble, France nadia.cherradi@cea.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TPA-inducible sequence 11b/butyrate response factor 1 (TIS11b/BRF1) belongs to the tristetraprolin (TTP) family of zinc-finger proteins, which bind to mRNAs containing AU-rich elements in their 3'-untranslated region and target them for degradation. Regulation of TTP family function through phosphorylation by p38 MAP kinase and Akt/protein kinase B signaling pathways has been extensively studied. In contrast, the role of cAMP-dependent protein kinase (PKA) in the control of TTP family activity in mRNA decay remains largely unknown. Here we show that PKA activation induces TIS11b gene expression and protein phosphorylation. Site-directed mutagenesis combined with kinase assays and specific phosphosite immunodetection identified Ser-54 (S54) and Ser-334 (S334) as PKA target amino acids in vitro and in vivo. Phosphomimetic mutation of the C-terminal S334 markedly increased TIS11b half-life and, unexpectedly, enhanced TIS11b activity on mRNA decay. Examination of protein-protein interactions between TIS11b and components of the mRNA decay machinery revealed that mimicking phosphorylation at S334 enhances TIS11b interaction with the decapping coactivator Dcp1a, while preventing phosphorylation at S334 potentiates its interaction with the Ccr4-Not deadenylase complex subunit Cnot1. Collectively our findings establish for the first time that cAMP-elicited phosphorylation of TIS11b plays a key regulatory role in its mRNA decay-promoting function.

Indexed as

3' Untranslated RegionsAnimalsCell Culture TechniquesChlorocebus aethiopsCOS CellsCyclic AMPCyclic AMP-Dependent Protein KinasesEndoribonucleasesHumansIntracellular Signaling Peptides and ProteinsMutagenesis, Site-DirectedPhosphorylationProtein Interaction Domains and MotifsRNA-Binding ProteinsRNA, MessengerRNA Recognition Motif Proteins3' Untranslated RegionsBRF1 protein, humanCyclic AMPCyclic AMP-Dependent Protein KinasesDCP1A protein, humanEndoribonucleasesIntracellular Signaling Peptides and ProteinsRNA-Binding ProteinsRNA, MessengerRNA Recognition Motif ProteinsTATA-Binding Protein Associated FactorsTrans-ActivatorsTristetraprolin

Identifiers

PMID27708140
PMCPMC5170607

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.